Pipeline
Disease Area (Target)
Discovery
Optimization
IND Enabling
Phase 1
Immunology (TYK2 - CNS)
Immunology (TYK2 - Peripheral)
Immunology (RIPK2*)
Immunology (IL-4Rα)
*Seeking partnerships for RIPK2-targeting assets